A New Acetylcholinesterase Inhibitor from Green Glycosylation of Trachyloban-19-oic Acid by Mucor plumbeus

AUTOR(ES)

SANTOS, GABRIEL F. DOS, TAKAHASHI, JACQUELINE A.

FONTE

An. Acad. Bras. Ciênc.

DATA DE PUBLICAÇÃO

23/10/2017

RESUMO

ABSTRACT The in vitro metabolism of a widespread natural product, trachyloban-19-oic acid (1), by the fungal species Mucor plumbeus was studied in a sucrose-yeast liquid medium. Two products were isolated, and their structures were determined by spectroscopic means as 7β-hydroxytrachyloban-19-oic acid (5) and trachyloban-19-O-β-D-glucopyranosyl ester (6). To the best of our knowledge, compound 6 is herein reported by the first time in the literature. These compounds were assayed for acetylcholinesterase inhibition along with some related compounds. Compound 6 showed the highest acetylcholinesterase inhibitory activity at 10000 µg/mL among the tested compounds, a result (92.89%) comparable to the activity of the positive control, galanthamine (94.21%). Therefore, biotransformation of the natural product 1 by M. plumbeus produced a novel compound with potential as a new lead to develop anti-Alzheimer medicines.

Documentos Relacionados

• An Interesting Backbone Rearrangement and Novel Derivatives from the Biotransformation of Trachyloban-19-oic Acid by Rhizopus stolonifer
• A Mucor pusillus mutant defective in asparagine-linked glycosylation.
• Isolation of a Bacterial Inhibitor from Green Olives1
• Occurrence of an Inhibitor of Lactic Acid Bacteria in Green Olives1
• Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation